pneumovax

(redirected from Pneumococcal polysaccharide vaccine)
Also found in: Dictionary, Thesaurus, Acronyms, Wikipedia.
Related to Pneumococcal polysaccharide vaccine: pneumococcal vaccine, Pneumococcal conjugate vaccine

Pneumovax

A vaccine that is given to splenectomy patients to protect them against bacterial infections. Other vaccines include Pnu-Imune and Menomune.
Mentioned in: Splenectomy

pneumovax (nōōˑ·mō·vaksˈ),

n a vaccine for bacterial pneumonia that comprises polysaccharide compounds derived from 23 species of
Pneumococcus bacteria. Also called
pneumococcal polysaccharide vaccine, pneuomococcal vaccine, pneumococcal vaccine polyvalent, Pneumovax II, or
Pneumovax 23.
Enlarge picture
Pneumothorax.
References in periodicals archive ?
IRR, incidence rate ratio; PPV23-13, 23- valent pneumococcal polysaccharide vaccine serotype cases, excluding those also contained in the 13-valent pneumococcal conjugate vaccine; NVT, nonvaccine type serotype cases.
Immunogenicity and reactogenicity of 23-valent pneumococcal polysaccharide vaccine among pregnant Filipino women and placental transfer of antibodies," Vaccine, vol.
Get a flu shot every year and a one-time pneumococcal polysaccharide vaccine (PPV) after age 65.
Policy statement: recommendations for the prevention of pneumococcal infections, including the use of pneumococcal conjugate caccine (Prevnar), pneumococcal polysaccharide vaccine, and antibiotic prophylaxis.
All adults who are aged 65 years or older should receive 13-valent pneumococcal conjugate vaccine routinely in series with 23-valent pneumococcal polysaccharide vaccine, according to a new recommendation from the Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices.
Routine vaccination with PCV13 may not be sufficient to reduce the risk of invasive disease in patients with comorbidity, and administering 23-valent pneumococcal polysaccharide vaccine to all children with comorbidity at the earliest acceptable age should be considered," wrote Dr.
This updated label now includes information describing the use of the vaccine in preterm infants, children and adolescents with sickle cell disease who were previously vaccinated with the 23-valent pneumococcal polysaccharide vaccine, and adults with human immunodeficiency virus (HIV) infection who were previously vaccinated with the 23-valent pneumococcal polysaccharide vaccine.
Vaccines available for the most common organisms include the 23 valent pneumococcal polysaccharide vaccine, 7 valent protein conjugated pneumococcal vaccine, the H.
One involves a purified fusion protein (PFP-2) vaccine for respiratory syncytial virus, another focuses on pneumococcal polysaccharide vaccine, and a third is a pilot study of a group B streptococcus type 3 capsular polysaccharide vaccine conjugated to tetanus toxoid, Dr.
Recommended intervals for sequential use of PCV13 and PPSV23 for immunocompetent adults aged >65 years--Advisory Committee on Immunization Practices, United States Pneumococcal vaccine-naive persons aged [greater than or equal to] 65 years [ILLUSTRATION OMITTED] Persons who previously received PPSV23 at age [greater than or equal to] 65 years [ILLUSTRATION OMITTED] Persons who previously received PPSV23 before age 65 years who are now aged [greater than or equal to] 65 years [ILLUSTRATION OMITTED] Abbreviations: PCV13 = 13-valent pneumococcal conjugate vaccine; PPSV23 = 23-valent pneumococcal polysaccharide vaccine.

Full browser ?